Revised Definition of Pulmonary Hypertension and Approach to Management: A Clinical Primer

por Maron, Bradley A.
Publicado 2023

Introducing the Pulmonary Hypertension Thematic Series

por Maron, Bradley A.
Publicado 2023

Clarifying the Pulmonary Arterial Hypertension Molecular Landscape Using Functional Genetics

por Maron, Bradley A.
Publicado 2020

Pulmonary arterial hypertension: Rationale for using multiple vs. single drug therapy

por Maron, Bradley A.
Publicado 2020

Pulmonary arterial hypertension: Cellular and molecular changes in the lung

por Maron, Bradley A.
Publicado 2020

Molecular Mechanisms of Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension

por Leopold, Jane A., Maron, Bradley A.
Publicado 2016

Systems biology: An emerging strategy for discovering novel pathogenetic mechanisms that promote cardiovascular disease

por Maron, Bradley A., Leopold, Jane A.
Publicado 2016

TORward a Molecular Convergence Point in Pulmonary Arterial Hypertension With mTOR

por Maron, Bradley A., Wilkins, Martin R.
Publicado 2018

Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction. Where to Draw the Line

por Simon, Marc A., Maron, Bradley A.
Publicado 2019

Reply to Wu et al.

por Brittain, Evan L., Tedford, Ryan J., Maron, Bradley A.
Publicado 2023

Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities

por Steiner, Johannes, Wu, Wen-Chih, Jankowich, Matthew, Maron, Bradley A., Sharma, Satish, Choudhary, Gaurav
Publicado 2015

Real‐world use of inhaled treprostinil for lung disease‐pulmonary hypertension: A protocol for patient evaluation and prescribing

por Johnson, Shelsey W., Finlay, Lauren, Mathai, Stephen C., Goldstein, Ronald H., Maron, Bradley A.
Publicado 2022

Mild Pulmonary Hypertension Is Associated With Increased Mortality: A Systematic Review and Meta‐Analysis

por Kolte, Dhaval, Lakshmanan, Suvasini, Jankowich, Matthew D., Brittain, Evan L., Maron, Bradley A., Choudhary, Gaurav
Publicado 2018

Inflammation, immunity, and vascular remodeling in pulmonary hypertension; Evidence for complement involvement?

por Frid, Maria G., Thurman, Joshua M., Hansen, Kirk C., Maron, Bradley A., Stenmark, Kurt R.
Publicado 2020

Cardiovascular Diseases That Have Emerged From the Darkness

por Maron, Barry J., Maron, Martin S., Maurer, Mathew S., Rowin, Ethan J., Maron, Bradley A., Galiè, Nazzareno
Publicado 2021

Second International Pulmonary Hypertension/Heart Failure Symposium—Structural heart disease, right ventricular dysfunction, and stem cell therapy: The European Pediatric Pulmonary...

por Chouvarine, Philippe, Hysko, Klea, Chan, Stephen Y., Oliveira, Paulo, Maron, Bradley A., Kourembanas, Stella, Hansmann, Georg
Publicado 2023

Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure

por Oliveira, Rudolf K. F., Faria-Urbina, Mariana, Maron, Bradley A., Santos, Mario, Waxman, Aaron B., Systrom, David M.
Publicado 2017

Socioeconomically disadvantaged veterans experience treatment delays for pulmonary arterial hypertension

por Gillmeyer, Kari R., Rinne, Seppo T., Qian, Shirley X., Maron, Bradley A., Johnson, Shelsey W., Klings, Elizabeth S., Wiener, Renda S.
Publicado 2022

Perspectives on Cardiopulmonary Critical Care for Patients With COVID‐19: From Members of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative an...

por Maron, Bradley A., Gladwin, Mark T., Bonnet, Sebastien, De Jesus Perez, Vinicio, Perman, Sarah M., Yu, Paul B., Ichinose, Fumito
Publicado 2020

What Causes Hypertrophic Cardiomyopathy?

por Maron, Bradley A., Wang, Rui-Sheng, Carnethon, Mercedes R., Rowin, Ethan J., Loscalzo, Joseph, Maron, Barry J., Maron, Martin S.
Publicado 2022